In vivo, an orthotopic patient-derived SHH/p53-mut MB xenograft mouse model was used to assess tumor growth via bioluminescence imaging (BLI) and proliferation index through Ki-67 staining of tumor tissue. This evidence concerns the gene TP53 and neoplasm.